Almost double the volumefrom the US side. This is totally safe imho for US investors that are still fearful of investing in greenrush stocks. The only touching of product that BLO will be doing is by their trial subjects for testing the equipment. The Feds shouldn't have a problem with that. A lot of US investors aren't waiting for the Feds to get their shyt together or a banking act or whatever kind of a trigger will fully swing the doors open to start the US greenrush. There are huge trades by US investors getting on board with Canadian LPs and Canadian LP Aphria just picked up a beer bottling line in the US which I suspect is for cannabinoid infused beverages when the legalities are sorted out. Most investors in BLO can see the necessity as marijuana becomes more mainstream and socially legal and accepted. This is a much needed device for the times we live in and I am liking BLO for being the leader of the pack, which isn't very large by my calculation. If BLO has a working as advertised model that industry is willing to buy, I see no reason that a first out thc breathalzyer can't match the $37 range that Lifeloc shares got to for a blood alcohol device. I left $3 on the table when it got that high because this could go exponential sharepricewise. Every company that has drivers and operators will want one to cover their own liabilities and then society is going to want one in every police cruiser. Cannabix is a serious inventor, still at it, even after others have thrown in the towel. Last I looked Lifeloc was still 2-3 dollar range and there are like 1000 BAC breathalyzer manufacturers/suppliers. glta and dyodd